The Intrauterine devices Market is predicted to reach $ 1,768 USD Million by 2021 with a CAGR of 4.78 % according to Market Data Forecast report.

The Intrauterine devices Market is predicted to reach $ 1,768 USD Million by 2021 with a CAGR of 4.78 % according to Market Data Forecast report.

ID: 1098 | November 2016 | Region: Global


The Intrauterine devices Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Intrauterine devices Market is estimated to be $ 1,400 USD Million in 2016 and predicted to rise to $ 1,768 USD Million by the end of 2021 with a CAGR of 4.78 %. The market is segmented by Product type - Hormonal intrauterine devices and Copper intrauterine devices. Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. Intrauterine devices are small contraceptive devices, often T-shaped, containing either levonorgestrel or copper, which are injected into the uterus. They are an effective type of reversible birth control and are a form of long-acting contraception. Recent trends such as the growing incidence of unintended pregnancies are quickly gaining popularity as it helps to control gratuitous healthcare expenditure on abortions. This market is extremely competitive and is susceptible to various technical and research challenges, which facilitates the inorganic growth within the market. Local and regional vendors in this market compete on the basis of product quality, price, service, reputation, innovation, promotion and distribution to gain maximum market traction. Major factors that influence the growth of the market are advancement in technical innovations, increasing prevalence of STD’S (Sexually transmitted diseases), immediate health benefits other than birth control, Rise in government initiatives to prevent unwanted abortions and pregnancies. Restraints that are hindering the growth of the market are Cultural or religious oppositions prevalent in many countries, Economic constraints, Infertility issues, ectopic pregnancy, pelvic inflammatory infection and Limited access to contraception.The Hormonal intrauterine devices is expected to account the highest share in the market due to their less risks and complications compared to non-hormonal IUD’S. Different geographical region has a different trend of using IUDs. IUDs are most popular in Europe; Scandinavian countries, Norway and Sweden have noted the highest use of IUD and hormonal IUDs are most popular in these countries. Some of the Asian countries continue to use traditional methods of contraception while countries like China have about 42% of people using IUDs. Asia-Pacific region has the largest share of market for IUDs. Some of the major companies influencing intrauterine devices market are Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals, Inc, Bayer, Teva Pharmaceutical, Besins HealthCare, Brecuro Medical, Effik International, Eurogine, HLL Lifecare, HRA Pharma, Lupin Pharmaceuticals, Ltd, Okamato Industries, Inc, Pfizer. Browse through the full report at “http://www.marketdataforecast.com/market-reports/global-intrauterine-devices-market-1092/” and checkout our recent reports in the Medical Devices category at “http://www.marketdataforecast.com/research-reports/healthcare/medical-devices-2/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.